These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 27298379

  • 1. Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis: a randomised placebo-controlled trial.
    Bhardwaj A, Kedarisetty CK, Vashishtha C, Bhadoria AS, Jindal A, Kumar G, Choudhary A, Shasthry SM, Maiwall R, Kumar M, Bhatia V, Sarin SK.
    Gut; 2017 Oct; 66(10):1838-1843. PubMed ID: 27298379
    [Abstract] [Full Text] [Related]

  • 2. Carvedilol vs. esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: a multicentre randomized controlled trial.
    Shah HA, Azam Z, Rauf J, Abid S, Hamid S, Jafri W, Khalid A, Ismail FW, Parkash O, Subhan A, Munir SM.
    J Hepatol; 2014 Apr; 60(4):757-64. PubMed ID: 24291366
    [Abstract] [Full Text] [Related]

  • 3. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol.
    Reiberger T, Ulbrich G, Ferlitsch A, Payer BA, Schwabl P, Pinter M, Heinisch BB, Trauner M, Kramer L, Peck-Radosavljevic M, Vienna Hepatic Hemodynamic Lab.
    Gut; 2013 Nov; 62(11):1634-41. PubMed ID: 23250049
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Carvedilol to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by liver stiffness: study protocol for a randomied, double-blind, placebo-controlled, multicentre trial in China.
    Liu C, Zhang L, Zhang S, Li X, Wong YJ, Liang X, Wang Y, Wu X, Gou W, Lv J, Hu S, Fu J, Huang J, Ge G, Huang M, Wang F, Zhang Q, Ren T, Meng Z, Ding D, Zhuoga B, Zhuoga C, Fan J, Dang D, Miao L, Song Z, Xiao X, Wu H, Jiang K, Liu T, Gao Y, Ma L, Fang T, Wang Y, Zhang Q, Zhu D, Ji D, Cao Z, Zeng QL, Li J, Chen P, Wei Y, Tong Z, Hong Z, Liang X, Li Y, Nan Y, Qi X.
    BMJ Open; 2024 Jul 11; 14(7):e081623. PubMed ID: 38991669
    [Abstract] [Full Text] [Related]

  • 6. Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of oesophageal varices: study protocol for a randomised controlled trial.
    Patel VC, McPhail MJ, Uddin R, Jafari H, Lawrence V, Le Boutillier C, Shearer J, Yaziji N, Cape A, Ahmed H, Ward C, Walsh P, Besly K, Zamalloa A, Kelly J, BOPPP study group, Carter B.
    Trials; 2024 Apr 16; 25(1):265. PubMed ID: 38627804
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis.
    Li T, Ke W, Sun P, Chen X, Belgaumkar A, Huang Y, Xian W, Li J, Zheng Q.
    BMJ Open; 2016 May 04; 6(5):e010902. PubMed ID: 27147389
    [Abstract] [Full Text] [Related]

  • 9. Hemodynamic Effects of Adding Simvastatin to Carvedilol for Primary Prophylaxis of Variceal Bleeding: A Randomized Controlled Trial.
    Vijayaraghavan R, Jindal A, Arora V, Choudhary A, Kumar G, Sarin SK.
    Am J Gastroenterol; 2020 May 04; 115(5):729-737. PubMed ID: 32079861
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
    Bañares R, Moitinho E, Piqueras B, Casado M, García-Pagán JC, de Diego A, Bosch J.
    Hepatology; 1999 Jul 04; 30(1):79-83. PubMed ID: 10385642
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Acute and 7-day portal pressure response to carvedilol and propranolol in cirrhotics.
    De BK, Das D, Sen S, Biswas PK, Mandal SK, Majumdar D, Maity AK.
    J Gastroenterol Hepatol; 2002 Feb 04; 17(2):183-9. PubMed ID: 11966949
    [Abstract] [Full Text] [Related]

  • 14. Hemodynamic effect of carvedilol vs. propranolol in cirrhotic patients: Systematic review and meta-analysis.
    Aguilar-Olivos N, Motola-Kuba M, Candia R, Arrese M, Méndez-Sánchez N, Uribe M, Chávez-Tapia NC.
    Ann Hepatol; 2014 Feb 04; 13(4):420-8. PubMed ID: 24927613
    [Abstract] [Full Text] [Related]

  • 15. Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised study.
    Hobolth L, Bendtsen F, Hansen EF, Møller S.
    Dig Liver Dis; 2014 Mar 04; 46(3):251-6. PubMed ID: 24290869
    [Abstract] [Full Text] [Related]

  • 16. Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed.
    Tripathi D, Ferguson JW, Kochar N, Leithead JA, Therapondos G, McAvoy NC, Stanley AJ, Forrest EH, Hislop WS, Mills PR, Hayes PC.
    Hepatology; 2009 Sep 04; 50(3):825-33. PubMed ID: 19610055
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of carvedilol for the treatment of portal hypertension.
    Hemstreet BA.
    Pharmacotherapy; 2004 Jan 04; 24(1):94-104. PubMed ID: 14740791
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of carvedilol versus propranolol versus variceal band ligation for primary prevention of variceal bleeding.
    Abd ElRahim AY, Fouad R, Khairy M, Elsharkawy A, Fathalah W, Khatamish H, Khorshid O, Moussa M, Seyam M.
    Hepatol Int; 2018 Jan 04; 12(1):75-82. PubMed ID: 29185106
    [Abstract] [Full Text] [Related]

  • 20. Clinical trial: The effect of somatostatin vs. octreotide in preventing post-endoscopic increase in hepatic venous pressure gradient in cirrhotics with bleeding varices.
    Vlachogiannakos J, Kougioumtzian A, Triantos C, Viazis N, Sgouros S, Manolakopoulos S, Saveriadis A, Markoglou C, Economopoulos T, Karamanolis DG.
    Aliment Pharmacol Ther; 2007 Dec 04; 26(11-12):1479-87. PubMed ID: 17919272
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.